approval
saveONDANSETRON — FDA approval
November 13, 2025updated 5mo ago
community read0 votes
Sponsor: BARR. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalONDANSETRON — FDA approvalNov 13, 2025
- approvalondansetron ODT: ONDANSETRON — FDA approvalNov 17, 2025
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalNov 6, 2025
- approvalLumify: QOLIANA (BRIMONIDINE TARTRATE) — FDA approvalNov 21, 2025
- approvalONDANSETRON — FDA approvalNov 24, 2025
- approvalnatalizumab biosimilar: TYRUKO (NATALIZUMAB-SZTN) — FDA approvalOct 30, 2025
🐶 often sniffed alongside
top 8- tagApproval58 co-mentions · 29 sources
- drugHYRIMOZ26 co-mentions · 13 sources
- drugLarotid14 co-mentions · 7 sources
- drugamoxicillin14 co-mentions · 7 sources
- drugVOQUEZNA DUAL PAK14 co-mentions · 7 sources
- drugAMOXICILLIN AND CLAVULANATE POTASSIUM14 co-mentions · 7 sources
- drugVOQUEZNA TRIPLE PAK14 co-mentions · 7 sources
- drugHUMIRA13 co-mentions · 13 sources
comments(0)
5-min edit window · permanent after that